Globus growth group, inc. Invests in restricted securities and securities which are not readily marketable. The company's primary activity is to invest in companies through venture capital investments in new and developing companies. Some of the investee companies are interface systems, inc., kimeragen, inc., repligen corporation, genitope corporation and thermaphore sciences, inc. Investment income accounted for 86% of fiscal 2000 revenues; consulting and other income, 12% and interest and dividend income, 2%.
